CN1150021A - 清肠剂 - Google Patents
清肠剂 Download PDFInfo
- Publication number
- CN1150021A CN1150021A CN 96116215 CN96116215A CN1150021A CN 1150021 A CN1150021 A CN 1150021A CN 96116215 CN96116215 CN 96116215 CN 96116215 A CN96116215 A CN 96116215A CN 1150021 A CN1150021 A CN 1150021A
- Authority
- CN
- China
- Prior art keywords
- clearing agent
- polyethylene glycol
- chloride
- sodium
- potassium chloride
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000000936 intestine Anatomy 0.000 title abstract description 4
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims abstract description 12
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims abstract description 12
- 239000002202 Polyethylene glycol Substances 0.000 claims abstract description 7
- 229920001223 polyethylene glycol Polymers 0.000 claims abstract description 7
- 239000001103 potassium chloride Substances 0.000 claims abstract description 6
- 235000011164 potassium chloride Nutrition 0.000 claims abstract description 6
- 239000011780 sodium chloride Substances 0.000 claims abstract description 6
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims abstract description 5
- 239000003795 chemical substances by application Substances 0.000 claims abstract 3
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 5
- 239000003792 electrolyte Substances 0.000 claims description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 3
- 230000000968 intestinal effect Effects 0.000 abstract description 4
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 abstract description 3
- 235000002639 sodium chloride Nutrition 0.000 abstract description 3
- 239000000126 substance Substances 0.000 abstract description 3
- 231100000957 no side effect Toxicity 0.000 abstract description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 3
- 229930195725 Mannitol Natural products 0.000 description 3
- 239000003599 detergent Substances 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000000594 mannitol Substances 0.000 description 3
- 235000010355 mannitol Nutrition 0.000 description 3
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 210000004400 mucous membrane Anatomy 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 229940076742 senna leaves Drugs 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 206010017999 Gastrointestinal pain Diseases 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 238000012084 abdominal surgery Methods 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001839 endoscopy Methods 0.000 description 1
- 238000004880 explosion Methods 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 239000008141 laxative Substances 0.000 description 1
- 230000002475 laxative effect Effects 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明公开了一种清肠剂,它主要由聚乙二醇和氯化钠、氯化钾、碳酸氢钠、无水硫酸钠等组成,该清肠剂既能干净地清除肠内物质,又对人体没有副作用和不适感,而且在检查时造影清晰。
Description
本发明涉及一种清肠药物。
消化道疾病的诊断,需做各种造影,如X光钡透、内窥镜检查、X光检查结肠,腹腔手术前检查,而造影前必须用清肠剂予以清肠;过去常用的清肠剂有甘露醇、硫酸镁、番泻叶等,虽有一定效果,但也有一定的副作用,如甘露醇服用后会引起体内脱水,使血液浓度增加,对某些心脏病人会产生不良后果,同时,甘露醇在体内还会分解后产生氢气,在作内窥镜通电检查治疗时,有引起爆炸的危险;番泻叶服用后使肠蠕动增加,容易发生肠痉挛疼痛,粘膜呈充血反应,由于痉挛性疼痛使肠内物质清除不干净。
本发明的目的是:提供一种清肠剂,它既能干净地清除肠内物质,又对人体没有副作用和不适感,而且在检查时造影清晰。
本发明的技术方案是:
一种清肠剂,其配方包括下列成份:
(1).聚乙二醇 28--36;
(2).电解质 4--6。
本发明进一步的技术方案是:
一种清肠剂,其配方包括下列成份:
(1).聚乙二醇 28--36;
(2).氯化钠 0.66--0.8;
(3).氯化钾 0.335--0.415;
(4).碳酸氢钠 0.76--0.92;
(5).无水硫酸钠2.5--3.1。
本发明的优点是:
1.由于本发明采用了无毒和肠胃不吸收的聚乙二醇为原料,加上电介质氯化钠、氯化钾、碳酸氢钠、无水硫酸铜组成,所以在有极好的清肠作用,且能维持体液的等渗,所以在服用后能将肠内物质清泻干净,无任何不适感和副作用。
2.由于要本发明服用后不失水,不使电解质吝乱,所以对粘膜不会造成充血,所以对年老体弱者及怀孕妇女都能适用,对任何患者均无禁忌,还可以作为严重便秘者有效的导泻药。
下面结合实施例对本发明作进一步的描述:
实施例:一种清肠剂,采用下列配方:
(1).聚乙二醇 32;
(2).氯化钠 0.73;
(3).氯化钾 0.375;
(4).碳酸氢钠 0.84;
(5).无水硫酸钠 2.84。
采用下列工艺:
将聚乙二醇冷冻干燥后打成细粉,将氯化钠、氯化钾、碳酸氢钠、无水硫酸钠打成细粉,然后混合均匀;服用时,将药粉加温开水,溶解后口服。
Claims (2)
1.一种清肠剂,其配方包括下列成份:
(1).聚乙二醇 28--36;
(2).电解质 4--6。
2.根据权利要求1所述的清肠剂,其特征在于:所述电解质的配方包括下列成份:
(1).氯化钠 0.66--0.8;
(2).氯化钾 0.335--0.415;
(3).碳酸氢钠 0.76--0.92;
(4).无水硫酸钠 2.5--3.1。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 96116215 CN1150021A (zh) | 1996-01-11 | 1996-01-11 | 清肠剂 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 96116215 CN1150021A (zh) | 1996-01-11 | 1996-01-11 | 清肠剂 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1150021A true CN1150021A (zh) | 1997-05-21 |
Family
ID=5123337
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 96116215 Pending CN1150021A (zh) | 1996-01-11 | 1996-01-11 | 清肠剂 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1150021A (zh) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100389779C (zh) * | 2006-07-07 | 2008-05-28 | 北京昭衍博纳新药研究有限公司 | 一种用于肠道清洁的药物组合物 |
| CN102772427A (zh) * | 2012-08-20 | 2012-11-14 | 深圳万和制药有限公司 | 一种复方聚乙二醇电解质组合物 |
| CN102805753A (zh) * | 2012-08-20 | 2012-12-05 | 深圳万和制药有限公司 | 包含聚乙二醇和电解质的药物组合物 |
| CN102805752A (zh) * | 2012-08-20 | 2012-12-05 | 深圳万和制药有限公司 | 复方聚乙二醇电解质散及其制备方法 |
| CN103393808A (zh) * | 2013-08-19 | 2013-11-20 | 王志英 | 一种用于孕后期引产前清肠的药物 |
| CN103989701A (zh) * | 2014-05-12 | 2014-08-20 | 中国人民解放军第二军医大学 | 聚乙二醇4000或聚乙二醇6000在制备预防或治疗水母毒素心脏毒性药物中的应用 |
| US8999313B2 (en) | 2012-09-11 | 2015-04-07 | Norgine Bv | Compositions |
| US9592252B2 (en) | 2011-03-11 | 2017-03-14 | Norgine Bv | Colonoscopy—preparation |
| CN112472718A (zh) * | 2020-12-01 | 2021-03-12 | 唐传生物科技(厦门)有限公司 | 改善口服清肠或肠道准备剂电解质紊乱副作用的组合物 |
-
1996
- 1996-01-11 CN CN 96116215 patent/CN1150021A/zh active Pending
Cited By (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100389779C (zh) * | 2006-07-07 | 2008-05-28 | 北京昭衍博纳新药研究有限公司 | 一种用于肠道清洁的药物组合物 |
| US9592252B2 (en) | 2011-03-11 | 2017-03-14 | Norgine Bv | Colonoscopy—preparation |
| US11529368B2 (en) | 2011-03-11 | 2022-12-20 | Norgine Bv | Colonoscopy—preparation |
| US10792306B2 (en) | 2011-03-11 | 2020-10-06 | Norgine Bv | Colonoscopy—preparation |
| US10780112B2 (en) | 2011-03-11 | 2020-09-22 | Norgine Bv | Colonoscopy-preparation |
| US10646512B2 (en) | 2011-03-11 | 2020-05-12 | Norgine Bv | Colonoscopy - preparation |
| CN102772427B (zh) * | 2012-08-20 | 2014-02-05 | 深圳万和制药有限公司 | 一种复方聚乙二醇电解质组合物 |
| CN102805752B (zh) * | 2012-08-20 | 2014-04-02 | 深圳万和制药有限公司 | 复方聚乙二醇电解质散及其制备方法 |
| CN102772427A (zh) * | 2012-08-20 | 2012-11-14 | 深圳万和制药有限公司 | 一种复方聚乙二醇电解质组合物 |
| CN102805753A (zh) * | 2012-08-20 | 2012-12-05 | 深圳万和制药有限公司 | 包含聚乙二醇和电解质的药物组合物 |
| CN102805752A (zh) * | 2012-08-20 | 2012-12-05 | 深圳万和制药有限公司 | 复方聚乙二醇电解质散及其制备方法 |
| US9326969B2 (en) | 2012-09-11 | 2016-05-03 | Norgine Bv | Compositions |
| US9707297B2 (en) | 2012-09-11 | 2017-07-18 | Norgine Bv | Compositions |
| US10016504B2 (en) | 2012-09-11 | 2018-07-10 | Norgine Bv | Compositions |
| US10918723B2 (en) | 2012-09-11 | 2021-02-16 | Norgine Bv | Colon cleansing compositions and methods of use |
| US8999313B2 (en) | 2012-09-11 | 2015-04-07 | Norgine Bv | Compositions |
| US12083179B2 (en) | 2012-09-11 | 2024-09-10 | Norgine Bv | Colon cleansing compositions and method of use |
| CN103393808A (zh) * | 2013-08-19 | 2013-11-20 | 王志英 | 一种用于孕后期引产前清肠的药物 |
| CN103393808B (zh) * | 2013-08-19 | 2015-09-09 | 王志英 | 一种用于孕后期引产前清肠的药物 |
| CN103989701A (zh) * | 2014-05-12 | 2014-08-20 | 中国人民解放军第二军医大学 | 聚乙二醇4000或聚乙二醇6000在制备预防或治疗水母毒素心脏毒性药物中的应用 |
| CN112472718A (zh) * | 2020-12-01 | 2021-03-12 | 唐传生物科技(厦门)有限公司 | 改善口服清肠或肠道准备剂电解质紊乱副作用的组合物 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2774106B2 (ja) | 下剤水溶液 | |
| CN102648980B (zh) | 含可溶性粘合剂的结肠泻药组成物 | |
| CN101938994A (zh) | 肠道催泻剂及其用途 | |
| CN1150021A (zh) | 清肠剂 | |
| EP0406248B1 (de) | Verwendung von dimethylpolysiloxan zur behandlung von erkrankungen des gastrointestinaltraktes | |
| Beck | Toxic effects from bismuth subnitrate: with reports of cases to date | |
| Saw et al. | Ileocaecal Perforation and Bleeding-Are Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Responsible? | |
| Halata et al. | Gardner Syndrome: Early Presentation with a Desmoid Tumor: Discovery of Multiple Colonic Polyps. | |
| CN100389779C (zh) | 一种用于肠道清洁的药物组合物 | |
| RU2817173C1 (ru) | Способ эндоскопического гемостаза кровоточащих полипов желудочно-кишечного тракта | |
| Edlich et al. | Wangensteen's transformation of the treatment of intestinal obstruction from empiric craft to scientific discipline | |
| EARAR et al. | Digestive disorders in the oral cavity | |
| RU2196577C2 (ru) | Способ лечения перитонита | |
| Blackwood | The Food Tract | |
| RU2098132C1 (ru) | Способ ранней дифференциальной диагностики острого периостита и остеомиелита челюстей у детей | |
| RU2188020C2 (ru) | Способ лечения язвенной болезни желудка и двенадцатиперстной кишки | |
| SU1158164A1 (ru) | Способ лечени острой тонкокишечной непроходимости | |
| AU2002312652B2 (en) | Laxative preparation | |
| CN110339158A (zh) | 一种硫酸钠钾镁口服溶液及其制备方法 | |
| RB | Elb0tracto from Current literature | |
| Bewley | Report on practice of medicine | |
| McCLURE | A case of generalized scleroderma simulating oesophageal carcinoma | |
| Teaspoonful | Syrupi glycyrrhizœ, qs, ad. Jiv | |
| JPS649291B2 (zh) | ||
| Taylor et al. | THE OPERATIVE CORRECTION OF DEFORMITY IN GUNSHOT FRACTURES. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C01 | Deemed withdrawal of patent application (patent law 1993) | ||
| WD01 | Invention patent application deemed withdrawn after publication |